uy
Journal Home
Search for

Volume 183, Issue 2, Pages 441-447 (February 2010)


View previous. 12 of 132 View next.

Evaluation of and Treatment for Monosymptomatic Enuresis: A Standardization Document From the International Children's Continence Society

Tryggve NeveusaCorresponding Author Informationemail address, Paul Eggertb, Jonathan Evansc, Antonio Macedod, Søren Rittige, Serdar Tekgülf, Johan Vande Walleg, C.K. Yeungh, Lane Robsoni

Received 1 April 2009 published online 14 December 2009.

Refers to article:
Pediatric Urinary Incontinence—Shouldn't We Speak the Same Language? , 14 December 2009
Stuart B. Bauer
The Journal of Urology
February 2010 (Vol. 183, Issue 2, Pages 425-426)
Full Text | Full-Text PDF (88 KB)
Purpose

We provide updated, clinically useful recommendations for treating children with monosymptomatic nocturnal enuresis.

Materials and Methods

Evidence was gathered from the literature and experience was gathered from the authors with priority given to evidence when present. The draft document was circulated among all members of the International Children's Continence Society as well as other relevant expert associations before completion.

Results

Available evidence suggests that children with monosymptomatic nocturnal enuresis could primarily be treated by a primary care physician or an adequately educated nurse. The mainstays of primary evaluation are a proper history and a voiding chart. The mainstays of primary therapy are bladder advice, the enuresis alarm and/or desmopressin. Therapy resistant cases should be handled by a specialist doctor. Among the recommended second line therapies are anticholinergics and in select cases imipramine.

Conclusions

Enuresis in a child older than 5 years is not a trivial condition, and needs proper evaluation and treatment. This requires time but usually does not demand costly or invasive procedures.

a Nephrology Unit, Uppsala University Children's Hospital, Uppsala, Sweden

b Klinik für Allgemeine Pädiatrie der Christian-Albrechts-Universität, Kiel, Germany

c Nottingham University Hospitals National Health Service Trust Queens Medical Centre Campus, Nottingham, United Kingdom

d Pediatric Urology Section, Federal University of São Paulo, São Paulo, Brazil

e Department of Pediatrics, Aarhus University Hospital, Skejby, Aarhus, Denmark

f Section of Paediatric Urology, Department of Urology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

g Pediatric Nephrology Unit, Ghent University Hospital, Ghent, Belgium

h Department of Surgery, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China

i Calgary, Alberta, Canada

Corresponding Author InformationCorrespondence: Paediatric Nephrology, Nephrology Unit, Uppsala University Children's Hospital, 751 85 Uppsala, Sweden

 See Editorial on page 425.

 Financial interest and/or other relationship with Ferring.

PII: S0022-5347(09)02682-2

doi:10.1016/j.juro.2009.10.043


View previous. 12 of 132 View next.